Skip to content
healthcare.dev

Algenist

NDC 53407-138, Octinoxate, Titanium Dioxide, Zinc Oxide, cream, from Solazyme, Inc..

Product NDC
53407-138
Status
Listed
Labeler
Solazyme, Inc.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53407-138 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTINOXATE75 mg/mL
  • TITANIUM DIOXIDE20 mg/mL
  • ZINC OXIDE171 mg/mL
Package NDCNDC-11Package
53407-138-30534070138301 CARTON in 1 BOX (53407-138-30) / 1 JAR in 1 CARTON / 30 mL in 1 JAR

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 53407-138 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53407-138 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53407-138. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.